Key Points
Rahul Shah, VP-Equity Advisory, MOFSL, says all specialty businesses are firing up in Sun Pharma and the US business also is better vis--vis competitors..
So, Sun Pharma remains the top bet in the entire pharma basket..
A lot of pharma stocks are bottoming out but if I have to pick one, I think Sun Pharma will continue to outperform at current levels...
Pre-Covid most of the pharma stocks rallied and the same was the case with Biocon and then it has done nothing in the last two years..
So if I have to look at in terms of market cap, the stocks look cheap but in terms of valuation, it looks fully valued at current levels as well..
